Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for AIXC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 1.721M
March 31, 2026 2.030M
December 31, 2025 3.329M
September 30, 2025 4.923M
June 30, 2025 5.615M
March 31, 2025 2.814M
December 31, 2024 2.008M
September 30, 2024 4.454M
June 30, 2024 4.812M
March 31, 2024 4.525M
December 31, 2023 4.137M
September 30, 2023 5.957M
June 30, 2023 9.842M
March 31, 2023 9.714M
December 31, 2022 10.32M
September 30, 2022 7.043M
June 30, 2022 7.879M
March 31, 2022 5.192M
December 31, 2021 6.271M
September 30, 2021 5.558M
June 30, 2021 7.627M
March 31, 2021 9.505M
December 31, 2020
Date Value
September 30, 2020
June 30, 2020
March 31, 2020 1.672M
December 31, 2019 1.697M
September 30, 2019 2.837M
June 30, 2019 2.879M
March 31, 2019 4.132M
December 31, 2018 5.934M
September 30, 2018 2.553M
June 30, 2018 1.910M
March 31, 2018 0.8011M
December 31, 2017 2.708M
September 30, 2017 2.958M
June 30, 2017 2.783M
March 31, 2017 2.551M
December 31, 2016 3.134M
September 30, 2016 3.792M
June 30, 2016 2.748M
March 31, 2016 2.334M
December 31, 2015 1.355M
September 30, 2015 1.133M
June 30, 2015 2.364M
March 31, 2015 1.223M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Cibus, Inc. 298.64M
Arrowhead Pharmaceuticals, Inc. 1.646B
NovelStem International Corp. 2.097M
Oncolytics Biotech, Inc. 13.84M
Sangamo Therapeutics, Inc. 78.92M

Total Liabilities (Quarterly) Related Metrics